What BMAC Is
BMAC starts with a bone marrow aspirate, which is then concentrated so that the final injection contains more of the nucleated bone marrow cells, platelets, and bioactive signaling molecules than the starting sample. Bone marrow naturally contains a small number of stem cells and progenitor cells, but it also contains many other supportive cells and biologic factors, so BMAC is best understood as a concentrated healing environment rather than a pure stem cell product. That broader composition is one reason it continues to attract interest in cartilage, osteoarthritis, tendon, and joint-preservation care.
How BMAC May Work
The earlier hope was that injected marrow cells would simply turn into brand-new cartilage. Current research supports a more sophisticated and still encouraging view. BMAC may provide growth factors and stem-cell-related signals that help calm inflammation, support tissue repair, and may help reduce some of the enzymes and inflammatory signals that contribute to cartilage breakdown.
Is BMAC a Stem Cell Injection?
Patients often hear BMAC described as a stem cell treatment, and there is some truth in that conversation, but the full picture is better. Bone marrow may contain stem cells, and it clearly contains connective tissue progenitor cells and other cell populations with regenerative potential. At the same time, BMAC is not a purified stem cell drug. It is an autologous concentrate of bone marrow cells, progenitor cells, platelets, cytokines, and growth factors that may work together to support healing.
What BMAC May Help
BMAC is most often discussed for knee osteoarthritis, cartilage injury, and selected tendon or bone-related problems. It is especially attractive in joint-preservation care, where the goal is to improve pain and function while trying to keep the native joint working as well as possible for as long as possible. Published clinical studies suggest BMAC can improve symptoms in selected patients with knee osteoarthritis, although it should still be approached as an evidence-informed option rather than a guaranteed solution.
What Treatment Is Like
A BMAC procedure is more involved than PRP, but it is still commonly performed as an office-based or outpatient treatment. Bone marrow is aspirated through a needle, usually from the iliac crest, and the sample is then processed to concentrate the part of the marrow that contains the cells and growth factors of interest. Many patients accept the extra procedural step because they like the idea of a treatment derived from their own marrow.
Recovery and Expectations
Most patients can expect temporary soreness at the harvest site and at the injection site. Improvement, when it occurs, is usually gradual rather than immediate. That gradual pattern often fits well with the biologic purpose of the treatment, because BMAC is intended to support healing over time rather than simply numb pain for a few hours or days. The best outcomes are usually pursued alongside strengthening, mobility work, activity modification, and a broader plan to improve joint mechanics and reduce overload.
Safety and Regulatory Information
BMAC is widely used in orthopedic and sports medicine practice, and the published literature consistently describes it as safe when performed with proper technique and patient selection. The aspiration needles and concentration systems used to prepare BMAC are FDA-cleared medical devices, and BMAC itself is your own tissue processed at the point of care, which places it among the most straightforward regulatory categories in regenerative medicine. While the FDA has not approved BMAC specifically for orthopedic indications, off-label use of FDA-cleared devices is a standard and accepted part of medical practice. Florida has established a clear regulatory framework that specifically allows physicians to offer these therapies for orthopedic, wound-care, and pain-management purposes, with appropriate informed consent and patient protections built into the process.
Bottom Line
BMAC is an advanced autologous orthobiologic option used in nonsurgical orthopedics. It may contain stem cells, and it also provides a broader mix of progenitor cells, growth factors, platelets, and repair signals that may support healing, improve function, and possibly help slow some of the inflammatory and enzyme-driven processes involved in cartilage wear. For the right patient, BMAC can be an encouraging way to pursue joint preservation, reduce pain, and keep moving with confidence while staying within a nonsurgical treatment plan.
Sources
- American Academy of Orthopaedic Surgeons. Use of Stem Cells in Orthopaedics. OrthoInfo.
- U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies.
- Anz AW, et al. Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial. Arthroscopy. 2020.
- Kim GB, et al. Bone Marrow Aspirate Concentrate: Its Uses in Osteoarthritis. International Journal of Molecular Sciences. 2020.
- Florida Statutes, Section 458.3245, Stem cell therapy.
- Filardo G, Mandelbaum BR, Muschler GF, Rodeo SA, Nakamura N, eds. Orthobiologics: Injectable Therapies for the Musculoskeletal System. Springer; 2022.